Prof. Constantin Coussios is the Director of the Oxford
Institute of Biomedical Engineering. He received his BA, MEng and PhD in
Engineering from the University of Cambridge and was elected to the first
statutory chair in Biomedical Engineering at the University of Oxford in 2011,
with special responsibility for drug delivery and therapeutic devices. He
founded and heads the Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals
Laboratory (BUBBL), a research group of some 50 researchers today housed in the
Marcela wing of the Botnar Research Centre. He received the Silver Medal of the
Royal Academy of Engineering in 2017 for contributions to the translation of
novel medical technologies into clinical practice, was elected a Fellow of the
Academy in 2019, and was awarded an OBE in 2022 for services to biomedical
engineering.
Prof. Constantin Coussios is the Director of the Oxford
Institute of Biomedical Engineering. He received his BA, MEng and PhD in
Engineering from the University of Cambridge and was elected to the first
statutory chair in Biomedical Engineering at the University of Oxford in 2011,
with special responsibility for drug delivery and therapeutic devices. He
founded and heads the Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals
Laboratory (BUBBL), a research group of some 50 researchers today housed in the
Marcela wing of the Botnar Research Centre. He received the Silver Medal of the
Royal Academy of Engineering in 2017 for contributions to the translation of
novel medical technologies into clinical practice, was elected a Fellow of the
Academy in 2019, and was awarded an OBE in 2022 for services to biomedical
engineering.